Legend Biotech Corp (LEGN)
40.94
+1.19
(+2.99%)
USD |
NASDAQ |
Nov 22, 16:00
40.95
+0.01
(+0.02%)
After-Hours: 20:00
Legend Biotech Shareholders Equity (Quarterly): 1.116B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.116B |
| June 30, 2024 | 1.159B |
| March 31, 2024 | 1.164B |
| December 31, 2023 | 1.251B |
| September 30, 2023 | 1.340B |
| June 30, 2023 | 1.407B |
| March 31, 2023 | 653.16M |
| December 31, 2022 | 744.31M |
| June 30, 2022 | 562.63M |
| Date | Value |
|---|---|
| March 31, 2022 | 438.56M |
| December 31, 2021 | 765.94M |
| September 30, 2021 | 225.87M |
| March 31, 2021 | 206.45M |
| December 31, 2020 | 597.77M |
| September 30, 2020 | 334.90M |
| June 30, 2020 | 401.00M |
| March 31, 2020 | -15.88M |
| December 31, 2019 | -122.87M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-122.87M
Minimum
Dec 2019
1.407B
Maximum
Jun 2023
679.39M
Average
625.46M
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 70.16B |
| Ligand Pharmaceuticals Inc | 841.18M |
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 2.912M |
| IGC Pharma Inc | 7.377M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.736B |
| Total Liabilities (Quarterly) | 619.72M |
| Debt to Equity Ratio | 0.2658 |
| Current Ratio | 4.984 |
| Net Debt Paydown Yield | -0.06% |